rs1057519766
|
|
T |
0.720 |
GeneticVariation |
CLINVAR |
Reversal of acquired drug resistance in FLT3-mutated acute myeloid leukemia cells via distinct drug combination strategies.
|
24619500 |
2014 |
rs1057519766
|
|
C |
0.720 |
GeneticVariation |
CLINVAR |
Reversal of acquired drug resistance in FLT3-mutated acute myeloid leukemia cells via distinct drug combination strategies.
|
24619500 |
2014 |
rs1057519766
|
|
C |
0.720 |
GeneticVariation |
CLINVAR |
Gene expression analysis of AML patients with CBFB/MYH11 rearrangement and FLT3 N676K mutation showed a trend toward a specific expression profile.
|
23878140 |
2013 |
rs1057519766
|
|
T |
0.720 |
GeneticVariation |
CLINVAR |
Gene expression analysis of AML patients with CBFB/MYH11 rearrangement and FLT3 N676K mutation showed a trend toward a specific expression profile.
|
23878140 |
2013 |
rs1057519764
|
|
C |
0.710 |
GeneticVariation |
CLINVAR |
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.
|
22504184 |
2012 |
rs1057519764
|
|
T |
0.710 |
GeneticVariation |
CLINVAR |
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.
|
22504184 |
2012 |
rs1057520026
|
|
G |
0.710 |
GeneticVariation |
CLINVAR |
The other novel mutation, FLT3 K663Q, is the first AML-associated gain-of-function mutation located outside the JM and AL domains.
|
16990784 |
2006 |
rs376588714
|
|
C |
0.710 |
GeneticVariation |
CLINVAR |
Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD.
|
23430109 |
2013 |
rs376588714
|
|
C |
0.710 |
GeneticVariation |
CLINVAR |
Reversal of acquired drug resistance in FLT3-mutated acute myeloid leukemia cells via distinct drug combination strategies.
|
24619500 |
2014 |
rs376588714
|
|
C |
0.710 |
GeneticVariation |
CLINVAR |
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.
|
22504184 |
2012 |
rs1057519726
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Prospective study of 174 de novo acute myelogenous leukemias according to the WHO classification: subtypes, cytogenetic features and FLT3 mutations.
|
16573742 |
2006 |
rs1057519726
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Novel observation of three FLT3 codons mutated in tandem in an elderly acute myeloid leukaemia patient.
|
16371029 |
2006 |
rs1057519762
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.
|
22504184 |
2012 |
rs1057519762
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD.
|
23430109 |
2013 |
rs1057519762
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Reversal of acquired drug resistance in FLT3-mutated acute myeloid leukemia cells via distinct drug combination strategies.
|
24619500 |
2014 |
rs1057519763
|
|
AA |
0.700 |
GeneticVariation |
CLINVAR |
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.
|
22504184 |
2012 |
rs1057519765
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Reversal of acquired drug resistance in FLT3-mutated acute myeloid leukemia cells via distinct drug combination strategies.
|
24619500 |
2014 |
rs1057519765
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD.
|
23430109 |
2013 |
rs1057519765
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.
|
22504184 |
2012 |
rs1057519767
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD.
|
23430109 |
2013 |
rs1057519767
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Reversal of acquired drug resistance in FLT3-mutated acute myeloid leukemia cells via distinct drug combination strategies.
|
24619500 |
2014 |
rs1057519767
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.
|
22504184 |
2012 |
rs1057519768
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD.
|
23430109 |
2013 |
rs1057519768
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Reversal of acquired drug resistance in FLT3-mutated acute myeloid leukemia cells via distinct drug combination strategies.
|
24619500 |
2014 |
rs1057519768
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.
|
22504184 |
2012 |